ArticleCardiovascular diabetology2026
Plasma proteomic profiling deciphers molecular dynamics linking insulin resistance to multiple chronic diseases and mortality.
Article in Cardiovascular diabetology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundInsulin resistance (IR) correlates with a wide spectrum of diseases and death. However, the specific proteomic signatures of IR and their associations with health outcomes remain incompletely understood.
methodsLeveraging data of 2,920 plasma proteins from 19,556 individuals in UK biobank study, we employed the elastic net model to dissect IR-related proteins and construct proteomic signature scores. Cox proportional hazards model was fitted to examine the longitudinal associations of distinct IR indicators and their proteomic signatures with multiple chronic disease and mortality. Mediation analyses were conducted to explore the role of individual proteins and proteomic signatures in IR-disease associations.
resultsOver a mean follow-up of over 12 years, higher levels of IR surrogate makers were linked to cardiovascular-kidney-metabolic events and mortality, with eGDR outperforming other metrics in predictive discrimination. Furthermore, most IR proteomic signatures were prospectively associated with the incidence of type 2 diabetes mellitus, ischemic heart diseases, stroke, chronic kidney diseases, and mortality. Proteins associated with IR were primarily enriched in inflammation, immune response, and lipid metabolism, with immune-related proteins holding crucial roles. Multiple IR-disease associations were significantly mediated by proteomic signatures and specific proteins, like HAVCR1, CXCL17, and GDF15.
conclusionThis study probed into the plasma proteomic profiles in IR settings and the associations of relevant protein signatures with multiple chronic diseases and mortality, providing additional guidelines on targeted intervention strategies for cardiovascular-kidney-metabolic outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.